Form 4: Applied Energetics CSO Sells 10,000 Shares

Sentiment:

Insider Transaction Report


Applied Energetics' Chief Science Officer, Stephen McCahon, reported the sale of 10,000 common shares under a Rule 10b5-1 plan.

Summary

  • Stephen William McCahon, Chief Science Officer of Applied Energetics, Inc. (AERG), reported sales of common stock.
  • The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • On November 19, 2025, 1,100 shares of common stock, par value $0.001 per share, were sold at a price of $1.50 per share.
  • On November 21, 2025, 8,900 shares of common stock, par value $0.001 per share, were sold at a price of $1.51 per share.
  • Following these reported transactions, Stephen McCahon beneficially owns 12,792,861 shares of common stock directly.
  • McCahon also holds 1,585,000 Common Stock Purchase Warrants with an exercise price of $0.06, which became exercisable on May 24, 2019, and expire on May 24, 2029.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of insider stock sales made under a Rule 10b5-1 plan, which are often pre-scheduled and do not necessarily indicate a change in management's outlook on the company.

Negatives

  • Chief Science Officer Stephen McCahon sold a total of 10,000 shares of common stock.

Stakeholder Impact

  • Shareholders may interpret insider selling differently; it could be seen as a routine liquidity event or, by some, as a potential negative signal, though the 10b5-1 plan suggests pre-planning.

Key Dates

DateDescription
05/24/2019Common Stock Purchase Warrants became exercisable.
11/19/2025Sale of 1,100 shares of common stock by Stephen McCahon.
11/21/2025Sale of 8,900 shares of common stock by Stephen McCahon.
11/21/2025Date of signature for the filing by Stephen W. McCahon.
05/24/2029Expiration date of Common Stock Purchase Warrants.

Recommendation

hold

The filing details routine insider stock sales executed under a Rule 10b5-1 plan. While insider selling can sometimes be viewed negatively, these pre-scheduled transactions do not inherently signal a change in the company's fundamentals or management's long-term view. A 'hold' recommendation is appropriate as this filing alone does not provide sufficient new information to warrant a change in investment thesis, requiring further analysis of company performance and market conditions.

Keywords

AERG, Applied Energetics, Form 4, insider trading, stock sale, Stephen McCahon, Chief Science Officer, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.